Demo · fictional data for showcase purposes · Aimlitics
Back to Access

Patient pipeline

SP01001814

Hub HUB00501814 · Source specialty_pharmacy · Enrolled Dec 21, 2025 · 8 status events

Snapshot

As of last status event Jan 10, 2026, 12:00 AM

On therapy

In current status

197d

Since enrollment

258d

Last dispense

73d ago

Jun 24, 2026

Next expected refill

45d late

2026-07-22

PrescriberDana JohnsonDermatologyNPI 9809547052
PracticeHenry Allergy
PharmacyBioScripts SpecialtyNPI 7635057498
PayerCommercial
DiagnosisInfantile (acute) (chronic) eczemaL20.83

Status timeline

8 events, most recent first. Days-in-prior shows how long the patient sat in the previous status before the transition.

  1. Jan 10, 2026, 12:00 AM

    ShippedOn therapy2d in prior
  2. Jan 8, 2026, 12:00 AM

    ScheduledShipped3d in prior
  3. Jan 5, 2026, 12:00 AM

    Ready to shipScheduled1d in prior
  4. Jan 4, 2026, 12:00 AM

    PA approvedReady to ship1d in prior
  5. Jan 3, 2026, 12:00 AM

    PA pendingPA approved10d in prior
  6. Dec 24, 2025, 12:00 AM

    Benefit verificationPA pending2d in prior
  7. Dec 22, 2025, 12:00 AM

    EnrolledBenefit verification1d in prior
  8. Dec 21, 2025, 12:00 AM

    start →Enrolled

Dispense history

7 fills · 7 Vial total

#ShippedProductQtyDays supplyGap from priorNext expected
72026-06-24Lyseva 100mg Vial63459-1001-011Vial28d26d2026-07-22
62026-05-29Lyseva 100mg Vial63459-1001-011Vial28d29d2026-06-26
52026-04-30Lyseva 100mg Vial63459-1001-011Vial28d28d2026-05-28
42026-04-02Lyseva 100mg Vial63459-1001-011Vial28d26d2026-04-30
32026-03-07Lyseva 100mg Vial63459-1001-011Vial28d28d2026-04-04
22026-02-07Lyseva 100mg Vial63459-1001-011Vial28d30d2026-03-07
1new2026-01-08Lyseva 100mg Vial63459-1001-011Vial28d2026-02-05